Evaluation status available after sign-in
About the journal
Cancer Medicine is an open-access journal published by Wiley in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 4,970 USD. Declared review time at DOAJ: 19 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 2045-7634
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 4,970 USD
- Articles in DOAJ
- 7816
- Declared review time
- 19 weeks
- Declared peer-review model
- other
- Official website
- https://onlinelibrary.wiley.com/journal/20457634
Index listings
- DOAJ · 2012-08-27
- MEDLINE · 2012-01-01
- Indexing
- DOAJ · MEDLINE
- APC
- 4,970 USD
- Declared review time (DOAJ)
- 19 weeks
- Actual review time (measured)
- 208 days received→accepted — computed from PubMed (n=98)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
7816
Most recent article
last month
Average review time (journal-declared via DOAJ)
19weeks
Works in OpenAlex
9790
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
124
i10-index
4839
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2012-08-27
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 92%
- ORCID iDs in current deposits
- 90%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101595310
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Global Cancer Incidence and Screening
- Head and Neck Cancer Studies
- Cancer survivorship and care
- Breast Cancer Treatment Studies
- Cancer survivorship and care
Show all subjects (75)
- Cancer survivorship and care
- Cancer-related molecular mechanisms research
- Lung Cancer Diagnosis and Treatment
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
- Hepatocellular Carcinoma Treatment and Prognosis
- Colorectal Cancer Treatments and Studies
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Lung Cancer Research Studies
- Cancer Genomics and Diagnostics
- Lymphoma Diagnosis and Treatment
- Pancreatic and Hepatic Oncology Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Research Studies
- Esophageal Cancer Research and Treatment
- Lung Cancer Research Studies
- MicroRNA in disease regulation
- Pancreatic and Hepatic Oncology Research
- Inflammatory Biomarkers in Disease Prognosis
- Pancreatic and Hepatic Oncology Research
- Esophageal Cancer Research and Treatment
- Esophageal Cancer Research and Treatment
- Lymphoma Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Lung Cancer Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Inflammatory Biomarkers in Disease Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- Breast Cancer Treatment Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Breast Cancer Treatment Studies
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Glioma Diagnosis and Treatment
- Colorectal Cancer Surgical Treatments
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Cancer Cells and Metastasis
- Childhood Cancer Survivors' Quality of Life
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Childhood Cancer Survivors' Quality of Life
- Bladder and Urothelial Cancer Treatments
- Sarcoma Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- RNA modifications and cancer
- Cervical Cancer and HPV Research
- RNA modifications and cancer
- Colorectal Cancer Treatments and Studies
- Acute Myeloid Leukemia Research
- Ovarian cancer diagnosis and treatment
- Acute Myeloid Leukemia Research
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
Keywords (DOAJ)
- cancer biology
- cancer medicine
- cancer prevention
- bioinformatics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ